Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

CONMED Corp
Next earnings Jul 28, 2026 (after close) · consensus $1.13 EPS, $344M rev
Last earnings -2.3% on 2026-04-29
Revenue grew 5.2% YoY.
Middling fundamentals and a rich price (~65% above fair value) leave little margin of safety — a wait-and-see.
Sources: SEC EDGAR (CIK 0000816956, latest 10-Q filed 2026-04-30) · EODHD · as of 6/22/2026, 1:55:32 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
CONMED Corp shows $1.37B in FY2025 revenue (+5.2% YoY), a 3.4% net margin, and 4.6% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.01B | $1.05B | $1.24B | $1.31B | $1.37B |
| Gross profit | $568M | $571M | $676M | $733M | $750M |
| Operating income | $110M | $70.1M | $121M | $200M | $103M |
| Net income | $62.5M | -$80.6M | $64.5M | $132M | $47.1M |
| Diluted EPS | $1.94 | -$2.68 | $2.04 | $4.25 | $1.51 |
| Net margin | 6.2% | -7.7% | 5.2% | 10.1% | 3.4% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1483 tracked peers · median
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
| 2026-06-02 | Bronson David M. Director | Exercise | 668.00 | |
| 2026-06-02 | Council LaVerne H Director | Exercise | 668.00 | |
| 2026-06-02 | Farkas Charles Director | Exercise | 668.00 | |
| 2026-06-02 | Kaye Mark Director | Exercise | 668.00 | |
| 2026-06-02 | Schwarzentraub Barbara J Director | Exercise | 668.00 | |
| 2026-03-06 | Lalomia Brent Executive VP RA, QA | Exercise | 75.00 | |
| 2026-03-06 | Lalomia Brent Executive VP RA, QA | Tax | 26.00 @ $39.90 | $1.04K |
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.